Anbio Biotechnology (NNNN) stock
NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$3.65−0.23 (-5.93%)
Close on Nov 17, 2026Market cap $525.20MP/E 24.8Yield –
Anbio Biotechnology pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Anbio Biotechnology's pe ratio was 27.6× on Nov 11, 2026, against 418.4× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 27.6× | −509.4 |
| 2025 | Dec 31, 2025 | 537.0× | – |
See a number that looks wrong?